NASDAQ:BNTC

Benitec Biopharma Stock Insider Trading

Healthcare > Biotechnology

Buy BNTC

*Your capital is at risk

$11.71

-0.150 (-1.26%)

At Close: Jul 31, 2026

Benitec Biopharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 95.57. In total, the insiders bought 15.26M and sold 20.98M BNTC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	95.57
● Buy	15.26M shares
● Sell	20.98M shares
93% Buy Activity Moderate Positive Correlation
Buy Signal High Confidence Jul 27, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 95.57. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (93% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	100 000 Value: $521.0K
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	300 000 Value: $3.60M
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	5 294 Value: $20.7K
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	141 Value: $7K
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	1 034 Value: $82.6K
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	1 034 Value: $82.6K
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	5 294 Value: $20.7K
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	300 000 Value: $3.60M
Jan 01, 2025 Buy	Options (right to buy)	Mukadam Sophie Chief Operating Officer	C-Suite Officer	100 000 Value: $521.0K
Jan 01, 2025 Buy	Common Stock, par value $0.0001 per share	Mukadam Sophie Chief Operating Officer	C-Suite Officer	0 Value: $0
Dec 24, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	17 730 Value: $199.5K
Dec 24, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	2 288 Value: $25.7K
Dec 24, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	2 288 Value: $25.7K
Dec 24, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	17 730 Value: $199.5K
Dec 23, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	24 360 Value: $267.5K
Dec 23, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	3 142 Value: $34.5K
Dec 23, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	3 142 Value: $34.5K
Dec 23, 2024 Buy	Common stock, par value $0.0001 per share P-Purchase	Suvretta Capital Management, Llc	Director	24 360 Value: $267.5K
Dec 09, 2024 Buy	Options (right to buy) A-Award	Mehta Kishan Director	Director	35 000 Value: $426.3K
Dec 09, 2024 Buy	Options (right to buy) A-Award	Francis Peter Director	Director	35 000 Value: $426.3K
Dec 09, 2024 Buy	Options (right to buy) A-Award	Buchi J Kevin Director	Director	35 000 Value: $426.3K
Dec 09, 2024 Buy	Options (right to buy) A-Award	Smith Edward F Director	Director	35 000 Value: $426.3K
Dec 09, 2024 Buy	Options (right to buy) A-Award	Banks Jerel A. Chief Executive Officer	CEO / President	2 310 000 Value: $28.1M
Dec 09, 2024 Buy	Options (right to buy) A-Award	Boston Megan Executive Director	Officer	720 000 Value: $8.77M
Dec 09, 2024 Buy	Options (right to buy) A-Award	Boston Megan Executive Director	Officer	720 000 Value: $8.77M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BENITEC BIOPHARMA LIMITED

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company w...

Read Full Profile Here